Events

Apollo Therapeutics will be attending the European Academy of Dermatology and Venereology (EADV) Congress 2026 in Vienna, Austria, from September 30 to October 3. Data from our Phase 2a study of camoteskimab in atopic dermatitis will be featured in a scientific poster presented at the meeting.

We look forward to connecting with colleagues across the dermatology community and engaging in discussions throughout the meeting.